Medicare Enrolled

Dr. Marc Melser, MD

Urology Physician · Port Charlotte, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3410 TAMIAMI TRL, Port Charlotte, FL 33952
9412357281
In practice since 2006 (20 years)
NPI: 1063480085 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Melser from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melser? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Melser

Dr. Marc Melser is an urology physician in Port Charlotte, FL, with 20 years in practice. Based on federal Medicare data, Dr. Melser performed 37,293 Medicare services across 1,549 unique beneficiaries.

Between the years covered by Open Payments, Dr. Melser received a total of $6,274 from 45 pharmaceutical and/or device companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Melser is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 3% volume in FL$ $6,274 industry payments

Medicare Practice Summary

Medicare Utilization ↗
37,293
Medicare services
Top 3% in FL for urology physician
1,549
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,865 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone undecanoate injection (Aveed)35,251$1$6
Office visit, established patient (20-29 min)440$61$216
Office visit, established patient (10-19 min)313$39$129
Automated urinalysis275$2$10
Diagnostic exam of bladder and urethra using an endoscope122$171$668
Hospital follow-up visit, moderate complexity122$64$219
Bladder ultrasound after voiding103$8$60
Office visit, established patient (30-39 min)75$96$320
Initial hospital admission, moderate complexity67$101$418
Hospital follow-up visit, high complexity61$96$314
New patient office visit (30-44 min)60$77$325
Drug injection, under skin or into muscle59$10$71
Leuprolide acetate (for depot suspension), 7.5 mg56$132$685
New patient office visit (45-59 min)46$129$501
Limited ultrasound scan behind abdominal cavity42$44$343
Hospital follow-up visit, low complexity38$41$121
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle24$22$107
Simple bladder irrigation and/or instillation21$25$273
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope19$569$2,756
Electronic assessment of bladder emptying17$8$132
Biopsy of prostate gland16$102$730
Ultrasonic guidance for needle placement15$25$604
Initial hospital admission, high complexity14$140$595
Insertion of stent in ureter using an endoscope13$116$1,540
Crushing of stone of ureter with insertion of stent using an endoscope12$332$1,315
Imaging of urinary tract following injection of a contrast agent12$20$513
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
95.2% medium
4.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,274
Total received (2018-2024)
Avg $896/year across 7 years
Top 34% in FL for urology physician
45
Companies
209
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,584 (89.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$690 (11.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,921
2023
$652
2022
$771
2021
$729
2020
$459
2019
$550
2018
$1,192

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$1,384
Endo Pharmaceuticals Inc.
$1,069
Janssen Biotech, Inc.
$771
Astellas Pharma US Inc
$530
Myriad Genetic Laboratories, Inc.
$240
PFIZER INC.
$222
Antares Pharma, Inc.
$177
Janssen Scientific Affairs, LLC
$176
Augmenix, Inc.
$161
BOSTON SCIENTIFIC CORPORATION
$146
Endo USA, Inc.
$144
Medtronic USA, Inc.
$87
Coloplast Corp
$87
Merck Sharp & Dohme Corporation
$85
Sumitomo Pharma America, Inc.
$85
Novartis Pharmaceuticals Corporation
$83
Travere Therapeutics, Inc.
$72
Supernus Pharmaceuticals, Inc.
$61
Janssen Products, LP
$60
Blue Earth Diagnostics Limited
$59
Boston Scientific Corporation
$56
Dendreon Pharmaceuticals LLC
$50
Allergan, Inc.
$39
Acerus Pharmaceuticals Corporation
$37
C. R. Bard, Inc. & Subsidiaries
$31
COLOPLAST CORP
$30
Myovant Sciences Inc.
$27
Telix Pharmaceuticals
$26
180 Medical, Inc.
$24
Avadel Specialty Pharmaceuticals, LLC
$23
Amgen Inc.
$22
Teleflex LLC
$21
Tolmar, Inc.
$18
CIVCO Medical Instruments
$18
UROVANT SCIENCES INC
$16
ABBVIE INC.
$16
Allergan Inc.
$15
TOLMAR Pharmaceuticals, Inc.
$15
Cook Medical LLC
$14
Kerecis Limited
$14
PRN Medical Services, LLC
$13
DENTSPLY IH Inc.
$13
AbbVie, Inc.
$12
Retrophin, Inc.
$12
Wilmington Medical Supply, Inc.
$11
Top 3 companies account for 51.4% of total payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM SYSTEM · AVEED · Axumin · BOTOX · BRACAnalysis CDx · Bard Urinary Drainage Bag · CONTINENCE CARE · COOK MEDICAL EXTRACTORS · EDEX · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL BPH · ILLUCCIX · INTERSTIM · KEYTRUDA · Kerecis Omega3 SurgiClose · LITHOVUE · LoFric · Lupron · Myrbetriq · NOCDURNA · Natesto · Noctiva · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · Prolaris · Prolia · RED RUBBER · REZUM · SELF-CATH · SPACEOAR VUE · SPEEDICATH · Self-Cath · SpaceOAR · SpeediCath · TESTOPEL · TOVIAZ · Thiola · Titan · UROLIFT · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $17 per 100 Medicare services performed
Looking for a urology physician in Port Charlotte?
Compare urology physicians in the Port Charlotte area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
19
Per 100K population
9.7
County median income
$66,154
Nearest hospital
Adventhealth Port Charlotte
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Melser is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Melser experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Melser performed 35,251 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Melser receive payments from pharmaceutical companies?
Yes. Dr. Melser received a total of $6,274 from 45 companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melser's costs compare to other urology physicians in Port Charlotte?
Dr. Melser's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melser) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →